WESTFORD Mass Dec GLOBE NEWSWIRE -- Kadant Inc NYSE KAI has entered into a definitive agreement to acquire Key Knife Inc and certain of its affiliates Key Knife for approximately million in cash subject to certain customary adjustments The acquisition is expected to close in early January subject to the satisfaction of customary closing conditions and will be financed primarily...
Globe News Wire
COPENHAGEN Denmark Dec GLOBE NEWSWIRE -- Ascendis Pharma A S Nasdaq ASND today announced that Jan Mikkelsen President amp Chief Executive Officer Scott Smith Executive Vice President amp Chief Financial Officer and Kennett Sprog e Ph D Executive Vice President Head of Research amp Product Development will participate in the nd Annual J P Morgan Healthcare Conference Details Event nd...
DENVER Dec GLOBE NEWSWIRE -- Concrete Pumping Holdings Inc Nasdaq BBCP CPH or the Company a leading provider of concrete pumping and waste management services in the U S and U K will hold a conference call on Thursday January at p m Eastern time to discuss its financial results for the fourth quarter and fiscal year ended October The...
SOUTH SAN FRANCISCO Calif Dec GLOBE NEWSWIRE -- Titan Pharmaceuticals Inc NASDAQ TTNP Titan or the Company today announced that its Board of Directors has approved a -for- reverse stock split of the Company's common stock which will be effective following the filing of an amendment to the Company s Amended and Restated Certificate of Incorporation the Amendment The Company's...
Michael A Shriner BCB Bancorp Inc Names Michael A Shriner President and Chief Executive Officer BAYONNE N J Dec GLOBE NEWSWIRE -- BCB Bancorp Inc the Company NASDAQ BCBP the holding company for BCB Community Bank the Bank or BCB today announced that Michael A Shriner has been named President and Chief Executive Officer of BCB Bancorp and BCB Community...
NKGen Biotech s autologous clinical program product candidate SNK demonstrated improvement in neuroinflammation and cognitive function in patients with Alzheimer s Disease AD in its Phase dose-escalation safety trial SNK consists of a non-genetically modified NK cell product with enhanced cytotoxicity and activating receptor expression for the treatment of moderate AD Initial patient in this Phase a trial received billion...
FREMONT Calif Dec GLOBE NEWSWIRE -- Cytek Biosciences Inc Nasdaq CTKB a leading cell analysis solutions company today announced the company will be participating in the upcoming nd Annual J P Morgan Healthcare Conference in San Francisco CA CEO Dr Wenbin Jiang is scheduled to present and participate in a Q amp A session on Thursday January at a m...
WINNIPEG Manitoba Dec GLOBE NEWSWIRE -- Kane Biotech Inc TSX-V KNE OTCQB KNBIF the Company Kane or Kane Biotech announces today that on December the Company and Pivot I Financial Limited Partnership Pivot entered into a definitive agreement to amend the terms of the Company s amended and restated credit facility between Pivot and the Company dated August as amended...
HAMILTON Bermuda Dec GLOBE NEWSWIRE -- American Overseas Group Limited BSX AORE BH Pink Sheets AOREF PK AOG or the Company today reported consolidated net income available to common shareholders of million or per diluted share for the three months ended September This compares to consolidated net loss available to common shareholders of million or per diluted share for the...
SAN DIEGO Dec GLOBE NEWSWIRE -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired The Lovesac Company NASDAQ LOVE securities between March and August Lovesac designs manufactures and sells furniture marketing its products primarily through the lovesac com website as well as through showrooms at...
LITTLE ROCK Ark Dec GLOBE NEWSWIRE -- Bank OZK the Bank Nasdaq OZK expects to report fourth quarter and full year earnings after the market closes on Thursday January Management s comments on the fourth quarter and full year will be released simultaneously with the earnings press release and will be available on the Bank s investor relations website Management...
NEW YORK Dec GLOBE NEWSWIRE -- WHY Rosen Law Firm a global investor rights law firm announces an investigation of potential securities claims on behalf of shareholders of Milestone Pharmaceuticals Inc NASDAQ MIST resulting from allegations that Milestone may have issued materially misleading business information to the investing public SO WHAT If you purchased Milestone securities you may be entitled...